SAN DIEGO, May 16, 2017 — Medical Marijuana, Inc. (MJNA), the first publicly traded cannabis company in the United States, today announced that its subsidiary HempMeds® will bring their knowledge of the benefits from its line of CBD hemp oil supplements into Panama to exhibit at the XXXIII Congress of the Pan American Alliance of Medical Women event. The event will take place from 8:00 a.m. to 4:00 p.m. from May 17-20 in El Cangrejo, Panama at Hotel El Panama.
Attendees of the women’s medical conference, which is geared towards an integral approach to the health of a woman, who stop by the HempMeds® booth can expect to learn more about the Company’s unique line of CBD hemp oil supplements, including its groundbreaking Real Scientific Hemp Oil™ (RSHO™) and zero-THC Real Scientific Hemp Oil-X™ (RSHO-X™), the first-ever cannabis product to receive approval from the federal government of Mexico for importation.
“As the first company to bring legal cannabis products to Mexico, Brazil and Paraguay, we are proud that to showcase the benefits that our CBD products provide so many individuals in Latin America as we continue to expand access to medical cannabinoid products,” said CEO of Medical Marijuana, Inc. Dr. Stuart Titus. “Being able to be a part of this health event for women is a positive step forward to our ultimate goal of legally exporting our products to the Country to help those of Panama who suffer from debilitating medical conditions.”
In addition, renowned physician Dr. Carlos Aguirre-Velazquez will speak at the event on May 20th about a recent survey he conducted on children with refractory epilepsy, which found that out of 53 cases of children who were treated with CBD hemp oil, 60 percent showed a reduction in seizures. The product most commonly used in the survey was the only current legal option in Mexico, Medical Marijuana, Inc.’s RSHO-X™.
HempMeds® is a corporate portfolio company of Medical Marijuana, Inc. (OTC PINK: MJNA) and the Company’s exclusive master distributor and contracted marketing company, handling sales and distribution.
About Medical Marijuana, Inc.
Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally-friendly, economically sustainable businesses, while increasing shareholder value. For details on Medical Marijuana, Inc.’s portfolio and investment companies, visit www.medicalmarijuanainc.com.
FORWARD-LOOKING DISCLAIMER AND DISCLOSURES.
This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties. The statements in this press release have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease. The Company does not sell or distribute any products that are in violation of the United States Controlled Substances Act. The Company does sell and distribute hemp-based products.